Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair

Rhea-AI Summary

AppYea Inc. (OTCQB:APYP) has appointed Ron Mekler as an independent director and Chair of the Audit Committee, effective immediately. This strategic move aims to enhance the company's board and management using Mekler's extensive experience in finance and healthcare. Mekler previously served as CFO at Clalit Health Services, Israel's largest health organization, and has a robust background in various industries. He expressed confidence in AppYea's potential and its innovative sleep monitoring solutions, which are protected by multiple patents. This leadership change is expected to strengthen the firm's market position and attract partnerships.

Positive

• Ron Mekler's appointment is expected to bring valuable experience and connections to AppYea.
• Mekler's background in healthcare could enhance the company's credibility and strategic direction.
• The existing patent portfolio is seen as a strategic asset that may attract partnerships.

Negative

• None.

GAN YAVNE, ISRAEL / ACCESSWIRE / January 23, 2023 / AppYea Inc. (OTCQB:APYP) which focuses on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, is pleased to announce the addition of Ron Mekler as an independent director of the Company and Chair of the Audit Committee, effective immediately.

The appointment is intended to strengthen the board of directors and management of the company, using the experience and connections of Mr. Mekler.

During the last 20 years Mr. Mekler has been serving in key positions including as CFO at Clalit Health Services - The largest Health Services organization in Israel (more than 2,000 employees, 600,000 members) and Controller in several international Industrial and Real Estate Companies.

Mr. Mekler started his career as an intern at Price Water House Coopers (BIG4) - Specializing in Industrial, Real Estate and High-Tech Companies.

Mr. Mekler is a certified accountant since 2003 (from BGU University) and has MBA in Business Management from the Ono Academic College.

"I am happy to take part in AppYea and believe in the potential of the company and its products in the international market. In recent years, we have seen a growing awareness of the importance of sleep monitoring in general and sleep breathing monitoring in particular, as evidenced by the entry of giant companies into the field. I think this trend will continue. I believe that the company's patent portfolio is a strategic asset that will attract companies to cooperate with the AppYea," said Mr. Mekler.

"I congratulate Ron on joining the team and thank him for expressing his trust in the company. I am convinced that Ron will contribute from his vast experience and professionalism to the advancement of the company." Said Boris (Bary) Molchadsky, the Chairman and CEO of AppYea.

About SleepX

SleepX is the research and development subsidiary of AppYea. The Company has developed a unique product for monitoring and treating sleep apnea and snoring. The technology is protected by several international patents. The Company currently focuses its activities on commercialization of its first product DreamIT.

Cautionary Note Regarding Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, timing of product development, FDA approval/clearance of products in development, customer acceptance of our products in the market, the introduction of competitive products, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the S-1 resale registration statement filed with the Securities and Exchange Commission. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

Contact:

Asaf Porat, CFO
asaf@sleepxclear.com
+972-546-864-110

SOURCE: AppYea Inc.

View source version on accesswire.com:
https://www.accesswire.com/736244/Ron-Mekler-Joins-AppYeas-Board-of-Directors-Audit-Committee-Chair

FAQ

What changes has AppYea made to its board of directors recently?

AppYea has appointed Ron Mekler as an independent director and Chair of the Audit Committee.

Why was Ron Mekler appointed as Chair of the Audit Committee for AppYea?

Ron Mekler was chosen to strengthen the board with his extensive experience in finance and healthcare.

What is the significance of Ron Mekler's background for AppYea?

Mekler's experience as CFO at Clalit Health Services and in various industries can provide valuable insights and strengthen AppYea's strategic direction.

How might Ron Mekler's appointment impact AppYea's operations?

Mekler's connections and expertise are expected to help enhance AppYea's credibility and could lead to potential partnerships.

What is AppYea's focus in the healthcare market?

AppYea focuses on developing wearable monitoring solutions for sleep apnea and snoring.